PLTR stock surges with solid Q2 results and raised guidance, while BBAI struggles with weak revenues and widening losses.

Mixed options sentiment in Palantir Technologies (PLTR), with shares up 36c, or 0.2%, near $181.95. Options volume relatively light with 239k ...

Shares of Palantir Technologies (NASDAQ: PLTR) have quadrupled in value during the past year and the company currently has a ...

Palantir Technologies Inc. (NASDAQ:PLTR) is one of the best big tech stocks to invest in now. On October 16, Palantir ...

Palantir's annual revenue surged from $1.1 billion in 2020 to $2.9 billion in 2024. It also turned profitable in 2023 and more than doubled its net income in 2024. That breakneck growth was driven by ...

Palantir Technologies (NASDAQ:PLTR) has taken the investing world by storm, and its share price has risen by over 2,000% ...

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of Class A common stock of Palantir Technologies Inc. (NASDAQ: PLTR).

The fund uses a synthetic covered call strategy to provide income and indirect exposure to the share price returns of PLTR, which is generally subject to a limit on potential investment gains as a ...

Despite elevated valuations, many investors remain not just optimistic—but emphatically confident. Their case hinges on one ...

The implementation of the controversial tech system for connecting trusts to a wide range of data will deliver almost £4 of ...

The Centers for Medicare & Medicaid Services appears to be quietly considering Palantir to support its yearslong efforts to ...

Cathie Wood's ARK Invest bought $5.56 million of Exact Sciences while selling $8.13 million of Guardant Health on0, 2025.